Skip to main content

Peer Review reports

From: Real-world effectiveness and safety of fingolimod in patients with multiple sclerosis in the Czech Republic: results from core and extension parts of the GOLEMS study up to 48 months

Original Submission
22 Oct 2021 Submitted Original manuscript
12 Dec 2021 Reviewed Reviewer Report
3 Jan 2022 Reviewed Reviewer Report
7 Jan 2022 Reviewed Reviewer Report - Rocco Haase
28 Jan 2022 Author responded Author comments - Veronika Tichá
Resubmission - Version 2
28 Jan 2022 Submitted Manuscript version 2
25 Feb 2022 Author responded Author comments - Veronika Tichá
Resubmission - Version 3
25 Feb 2022 Submitted Manuscript version 3
17 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
23 Mar 2022 Editorially accepted
15 Apr 2022 Article published 10.1186/s12883-022-02656-8

You can find further information about peer review here.

Back to article page